Revolutionizing treatment Of hypogonadism (low t) And related co-morbidities
Images shown on our website are not actual patients
Acesis BioMed is a Colorado (USA) & London (UK) based biomedical company operating through Acesis Holdings Corporation and its subsidiaries – Acesis Biomed US, Inc. and Acesis Biomed Ltd - developing a platform of oral drug candidates for metabolic and endocrine disorders, initially focusing on male hypogonadism treatment (low T)
1 Global Male Hypogonadism Market Size, Share 2021-2026 to Post a CAGR of Includes Business Research, Key players, Market Growth, Complete Industry Analysis, Revenue, Future Trends 2026 - MarketWatch